Shilpa Medicare Ltd. has entered into a memorandum of understanding (MoU) with LOBA Finchemie AG, Austria, to acquire 100 percent shares of LOBA in an all-cash deal. Shilpa is one of India's leading specialty pharmaceutical manufacturers with primary focus on custom synthesis and oncology APIs.
The formal terms will be announced after the due diligence process, currently on, is completed.
India, US Signs Agreement to Develop Low-cost Medical Technologies
India and the US Thursday signed an agreement to develop low-cost medical technologies and share expertise on biomedical research.
Advertisement
Founded in 1957, the privately-owned LOBA provides specialty APIs, organic intermediates, biochemical diagnostics, and customs synthesis. With facilities conforming to top Euro cGMP and USFDA specifications, LOBA counts some of the world's largest pharmaceutical and diagnostic companies as its business partners. The company's product range covers 500 organic compounds available from kilo-to-small ton quantities.
LOBA is a profit-making company, with current annual revenue at nearly 15 million dollars.
LOBA's acquisition, if successful, will fast forward Shilpa Medicare's vision of becoming India's leading manufacturer in the high growth oncology and CRAMS sectors, said Vishnukant Bhutada, Managing Director, Shilpa Medicare.
![Apollo Health Street Acquires US BPO Zavata Inc.]( "Apollo Health Street Acquires US BPO Zavata Inc.")
India's healthcare outsourcing company Apollo Health Street Limited has acquired Zavata Inc, an Atlanta-based business process outsourcing (BPO) unit for Rs.6.96 billion ($170 million).
"LOBA, with its product range, long-standing customer relationships in highly regulated markets, and internationally certified and compliant R&D and manufacturing facilities, is a perfect strategic fit for Shilpa Medicare. Given our highly skilled talent pool and low operational costs, the Shilpa-LOBA combination would be a formidable entity in the global oncology and CRAMS sectors," Bhutada said.
Source: ANI
SRM/V
LOBA's acquisition, if successful, will fast forward Shilpa Medicare's vision of becoming India's leading manufacturer in the high growth oncology and CRAMS sectors, said Vishnukant Bhutada, Managing Director, Shilpa Medicare.
Apollo Health Street Acquires US BPO Zavata Inc.
India's healthcare outsourcing company Apollo Health Street Limited has acquired Zavata Inc, an Atlanta-based business process outsourcing (BPO) unit for Rs.6.96 billion ($170 million).
Advertisement
"LOBA, with its product range, long-standing customer relationships in highly regulated markets, and internationally certified and compliant R&D and manufacturing facilities, is a perfect strategic fit for Shilpa Medicare. Given our highly skilled talent pool and low operational costs, the Shilpa-LOBA combination would be a formidable entity in the global oncology and CRAMS sectors," Bhutada said.
Source: ANI
SRM/V
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Corporate News
The first World Health Organisation (WHO)/ International Labour Organisation (ILO) joint global monitoring report shows that more action is needed to ensure healthier, safer, more resilient, and more social workplaces.
Successful career transitions could be possible when people leverage their existing skills in the new occupation. A new Artificial Intelligence tool helps employees figure out the right job according to their current skill set.
AI and big data rule the pharmaceutical sector by enhancing the drug development process and increasing the marketing and sales of drugs
Insurance companies in the US are working towards adding food to their coverage menu to improve the people's health under their coverage and cut hospital costs.
Pharmaceutical companies need to make strategic decisions that will provide financial benefit while showing strong commitment to global health and their patients during the pandemic.
